Lupus & antiphospholipid syndrome

Identification of clinical phenotypes and disease trajectories in systemic lupus erythematosus (SLE) using artificial intelligence (AI) through a natural language processing framework

Rheumatology (Oxford)Published Retrospective cohort study

Authors' conclusion

This novel framework, based on real-world data, enables longitudinal phenotype characterization of SLE patients.

Study context

Population
SLE patients from electronic health records (EHRs) with ≥1 hospitalization, ≥1 outpatient visit and follow-up ≥1.5 years; 88% female, median age 43 years, median follow-up 6 yearsof 1,000 extracted
Participants
262 patients
Exposure
High- vs medium- vs low-complexity phenotype at first contact
Outcome
Clinical phenotypes (clinical domains, disease complexity) and disease trajectories (flares) identified by NLP
Methodological detailsNatural language processing (NLP)-based pipeline, combined AI and human intelligence framework, ontology-based definitions
  • NLP-based pipeline
  • Combined AI and human intelligence framework
  • Ontology-based definitions

Main finding

As reported in the abstract

GroupValueFlares over time
High complexity43%5
Medium complexity35%3
Low complexity22%3

Value

High complexity43%
Medium complexity35%
Low complexity22%

Flares over time

High complexity5
Medium complexity3
Low complexity3
  • High complexity vs Medium complexity and Low complexity: P < 0.001 — 5 vs 3 and 3
Clinical domains at first contact: hematological
64%
Clinical domains at first contact: articular
47%
Clinical domains at first contact: cutaneous
59%
Clinical domains at first contact: renal
58%

Observational data: associations, not effects.

Further findings

New clinical domains and use of conventional immunosuppressants, biologics and GC during follow-up

Low and medium-complexity phenotypes showed a higher increase

Original publication

Identification of clinical phenotypes and disease trajectories in SLE using AI through a natural language processing framework. Rheumatology (Oxford). Published 17 February 2026. doi:10.1093/rheumatology/keag035

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.